Watchdog Group Wants FDA Leaders Removed for Okaying Aducanumab

Watchdog Group Wants FDA Leaders Removed for Okaying Aducanumab

Mo Africa News:

Backlash against the FDA’s action grows, while advocates who supported approval of the Alzheimer’s drug now are upset over its $56,000 cost. Medscape Medical News
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated